🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

21 recruiting trials

for Obese With Comorbidities

A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus NCT07784725Phase 3212 sites📍 Dothan📍 Huntsville📍 Mesa AstraZeneca · Tests: AZD6234, Placebo A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus NCT07776509Phase 396 sites📍 Escondido📍 Lincoln📍 Walnut Creek AstraZeneca · Tests: Lenbelintide, Placebo Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1) NCT07654361Phase 371 sites📍 Birmingham📍 Birmingham📍 Phoenix Gasherbrum Bio, Inc., a wholly owned subsidiary of Structur… · Tests: Aleniglipron, Placebo Comorbidities Resolution After MGB Surgery and Change in Body Composition NCT06015620n/a1 site📍 Bhubaneswar All India Institute of Medical Sciences, Bhubaneswar · Tests: Mini gastric bypass surgery Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities NCT07752979Phase 263 sites📍 Pelham📍 Scottsdale📍 Tucson AbbVie · Tests: ABBV-295, Placebo Digital Dietary Intervention for Patients Receiving GLP-1 Receptor Agonist Therapy NCT07728669NA1 site📍 Almaty Kazakh Academy of Nutrition · Tests: NutriSteppe Digital Dietary Intervention MORPH-A - Multidisciplinary Obesity Rehabilitation & Psychophysical Health and Awareness NCT07880847NA1 site📍 Pavia Istituti Clinici Scientifici Maugeri SpA · Tests: MAC Mutiltidisciplinary Rehabilitation Program, Routine Clinical and Care Management Metformin as Adjunct Therapy in Depression-obesity Comorbidity: Clinical and Genetic Evaluation NCT07654179NA2 sites📍 Rawalpindi📍 Rawalpindi Riphah International University · Tests: Metformin, Antidepressant Therapy A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities NCT07743463Phase 3122 sites📍 Birmingham📍 Huntsville📍 Phoenix Ascletis Pharma (China) Co., Limited · Tests: ASC30 tablets A1, Placebo A Study of Orforglipron (LY3502970) in Adolescent Participants With Obesity, or Overweight With Related Comorbidities NCT06672939Phase 334 sites📍 Oxnard📍 Stamford📍 Atlanta Eli Lilly and Company · Tests: Orforglipron, Placebo ENLIGHT Trial: ESG With Fundal Mucosal Ablation NCT07792226NA1 site📍 Morgantown West Virginia University · Tests: Endoscopic Sleeve Gastroplasty (ESG), Fundal Mucosal Ablation NUTRIMOOD-Inflammation and Depressive Comorbidity in Obesity: Modulation by Omega-3 Polyunsaturated Fatty Acids Status NCT07439744NA1 site📍 Taichung National Science and Technology Council, Taiwan · Tests: Eicosapentaenoic acid (omega-3 fatty acid), Placebo A Study of Tirzepatide in Adolescents With Obesity and Weight-Related Comorbidities (SURMOUNT-ADOLESCENTS-2) NCT06439277Phase 369 sites📍 Los Angeles📍 Sacramento📍 Wilmington Eli Lilly and Company · Tests: Tirzepatide, Placebo Effect of LY3437943 Versus Placebo in Participants Who Have Obesity or Are Overweight NCT07467447Phase 21 site📍 Shenzhen Hudson Biotech · Tests: Retatrutide (LY3437943), Placebo, Standardized diet and physical activity counseling throughout the study. A Study to Evaluate the Safety and Tolerability of Different Doses of CX11 Tablets NCT07652047Phase 12 sites📍 Las Vegas📍 Austin Corxel Pharmaceuticals · Tests: CX11, Placebo, CX11 Efficacy and Safety of HDM1005 in Chinese Obesity or Overweight Patients Without Diabetes NCT07279194Phase 31 site📍 Shanghai Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. · Tests: HDM1005 1, HDM1005 2, Placebo A Study of IBI362 in Chinese Adolescents With Obesity or Overweight NCT07255209Phase 31 site📍 Hangzhou Innovent Biologics (Suzhou) Co. Ltd. · Tests: Placebo, IBI362 Efficacy and Safety of GL0034 in Overweight or Obese Adults With Type II Diabetes Mellitus NCT07282743Phase 221 sites📍 Little Rock📍 Hialeah Gardens📍 Lakeland Sun Pharmaceutical Industries Limited · Tests: GL0034 Dose Level 1, GL0034 Dose Level 2, GL0034 Dose Level 3, GL0034 Dose Level 4, GL0034 Dose Level 5 A Study to Investigate the Efficacy and Safety of Two Different Doses of Twice Daily Distal Jejunal-release Dextrose Beads Formulations Combined With a Gel Composition Compared to Placebos in Obese Subjects With Weight Related Comorbidities NCT07008456Phase 26 sites📍 Tbilisi📍 Tbilisi📍 Tbilisi Aphaia Pharma US LLC · Tests: APHD-012, APHD-002, APHP-012, APHP-002 Efficacy and Safety of Tirzepatide Once Weekly Versus Placebo in Participants Who Are Either Obese or Overweight With Weight-Related Comorbidities (SURMOUNT-1) NCT07481747Phase 31 site📍 Shenzhen Hudson Biotech · Tests: Tirzepatide, Placebo, Reduced-calorie diet Lean Beef as Part of a Healthy Meal Plan in Adolescents With Polycystic Ovary Syndrome (PCOS)/Polyendocrine Metabolic Ovarian Syndrome (PMOS) NCT07780188NA1 site📍 College Station Texas A&M University · Tests: Beef+
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy